Author

Brayley S. Gattis

Observed names: B. Gattis, Brayley Gattis, Gattis, Brayley Soleil

Institutions: Northwestern University, International Institute for Nanotechnology, Chemistry of Life Processes Institute

Observed institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, International Institute for Nanotechnology, Chemistry of Life Processes Institute, University of Arkansas at Fayetteville

ORCID: 0000-0001-6813-9218

Observed ORCID: 0000-0001-6813-9218

OpenAlex ID: A5011613232

Electrochemical Control of the Morphology and Functional Properties of Hierarchically Structured, Dendritic Cu Surfaces

2022 · Hamed Mehrabi, Samuel K. Conlin, et al. · Energy Technology · 19

Proteomimetic Polymers Trigger Potent Antigen-Specific T Cell Responses to Limit Tumor Growth

2024 · Max M. Wang, Mi-Ran Choi, et al. · Journal of the American Chemical Society · 7

The Importance of Fire Extinguisher Training among Graduate Student Laboratory Teaching Assistants: A General Chemistry Laboratory Fire Incident

2023 · Casandra M. Moisanu, Brayley S. Gattis, et al. · ACS Chemical Health & Safety · 5

Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS

2026 · Max M. Wang, Mihai I. Truica, et al. · Nature Communications · 3

Use of proteomimetic polymers for delivery of tumor antigens and adjuvants through formation of stable electrostatic complexes with small molecule STING agonists.

2023 · Max Mu Wang, Brayley Gattis, et al. · Journal of Clinical Oncology · 1

Heterobifunctional proteomimetic polymers for targeted protein degradation

2025 · Max M. Wang, Mihai I. Truica, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Abstract 3882: Targeted degradation of undruggable proteins using a novel heterobifunctional proteomimetic platform

2024 · Max Wang, Mihai Truica, et al. · Cancer Research

Heterofunctional polymeric degrading chimeras (HYDRAC) for targeted protein degradation.

2023 · Max Mu Wang, Mihai Ioan Truica, et al. · Journal of Clinical Oncology

Abstract 2714: Inhibiting Myc using heterofunctional polymeric degrading chimeras (HYDRACs): a novel class of compounds capable of targeted protein degradation

2023 · Max M. Wang, Mihai I. Truica, et al. · Cancer Research

Abstract 813: The protein-like polymer (PLP): A tunable proteomimetic nanoplatform for the development of rationally designed cancer vaccines

2023 · Max M. Wang, Mi Ran Choi, et al. · Cancer Research

First-in-class heterobifunctional proteomimetic polymer capable of direct inhibition of Myc and target it for degradation

2022 · M. Wang, M. Trucia, et al. · European Journal of Cancer

Development of heterobifunctional proteomimetic polymers for delivery of MYC inhibitory peptides and targeted MYC degradation.

2022 · Mihai Ioan Truica, Max Mu Wang, et al. · Journal of Clinical Oncology

Works count: 13

Citation count: 35

H-index: 3

I10-index: 1